Biopharmaceuticals Products and Pipeline
 | | | | | | | | | |
|  |  |  |  |  |  |  |  | |
| Alzheimer's Disease Immunotherapies (with Wyeth) | ||||||||
| Bapineuzumab (AAB-001) Monoclonal Antibody Intravenous | ||||||||
| Bapineuzumab (AAB-001) Monoclonal Antibody Subcutaneous | ||||||||
| AAB-002 Monoclonal Antibody | ||||||||
| ACC-001 Immunoconjugate | ||||||||
| Alzheimer's Disease Abeta Aggregation Inhibitors (with Transition Therapeutics) | ||||||||
| ELND005 | ||||||||
| Alzheimer's Disease Secretase Inhibitors | ||||||||
| Beta Secretase Research | ||||||||
| Gamma Secretase Research | ||||||||
| Gamma Secretase Inhibitor (ELND007) | ||||||||
| Gamma Secretase Inhibitor (ELND006) | ||||||||
| Gamma Secretase Inhibitor (LY450139 – Eli Lilly) | ||||||||
| Parkinson's Disease | ||||||||
| Parkinson's Research | ||||||||
 | |||||||||
| Multiple Sclerosis (with Biogen Idec) | ||||||||
| TYSABRI® (natalizumab) (U.S.) | ||||||||
| TYSABRI® (natalizumab) (EU) | ||||||||
| TYSABRI® Subcutaneous | ||||||||
| Crohn's Disease (with Biogen Idec) | ||||||||
| TYSABRI® (natalizumab) (U.S.) | ||||||||
| Multiple Myeloma (with Biogen Idec) | ||||||||
| TYSABRI® (natalizumab) | ||||||||
| Small Molecules natalizumab follow-ons | ||||||||
| ELND002 | ||||||||
| ELND004 | ||||||||
| Autoimmune Research | ||||||||
 | |||||||||
| Severe Chronic Pain | ||||||||
| PRIALT® (ziconotide intrathecal infusion) (U.S.) | ||||||||
| Infectious Diseases | ||||||||
| AZACTAM® (aztreonam for injection, USP) (U.S.) | ||||||||
| MAXIPIME® (cefepime hydrochloride for injection) (U.S.) | ||||||||
Tip: Roll your mouse over the bars above to get an explanation of the phase they are at in the Pipeline.
 Download Printer Friendly PDF: | |||||||||
